Evidence map›Paper›PMID 25040262›Full record

ArticleBrain pathology (Zurich, Switzerland)2015

Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.

Jacquelyn J Roth, Mariarita Santi, Avrum N Pollock, Brian N Harding, Lucy B Rorke-Adams, Laura S Tooke, Jaclyn A Biegel

Open access · greenAbstract readCase Reports
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Targeted therapy for pediatric low-grade glioma.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Article
  4. Article
  5. Review
  6. A glioneuronal tumor withNPJ genomic medicine · 2020
    Article
  7. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2019
    Article
  8. Review
  9. Review
  10. Genome sequencing identifies somaticCold Spring Harbor molecular case studies · 2018
    Article
  11. Article
  12. Molecular Testing of Brain Tumor.Journal of pathology and translational medicine · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The evolving molecular genetics of low-grade glioma.Advances in anatomic pathology · 2015
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jacquelyn J RothDepartment of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA.
Mariarita Santi
Avrum N Pollock
Brian N Harding
Lucy B Rorke-Adams
Laura S Tooke
Jaclyn A Biegel
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

MEDICAL GENETICS RESEARCH TRAINING GRANTT32GM008638 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca Ganetzky · 1997 to 2026
$8.7M
Molecular Profiling and Candidate Gene Analysis in Pediatric GliomasR21CA133173 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI BIEGEL, JACLYN A · 2008 to 2009
$407k
NCI NIH HHS CA133173NCI NIH HHS R21 CA133173NIGMS NIH HHS T32 GM008638NIGMS NIH HHS T32-GM008638
6 · The paper itself

Abstract

The majority of pediatric low-grade gliomas (LGGs) are characterized by constitutive activation of the mitogen-activated protein kinase (MAPK) pathway through various mechanisms including BRAF mutations, inactivation of NF1, and KIAA1549-BRAF and FAM131B-BRAF fusions. The KIAA1549-BRAF fusion typically results from a 2.0 Mb tandem duplication in chromosome band 7q34. In the present study, single nucleotide polymorphism (SNP)-based array analysis of three LGGs demonstrated deletions in 7q34 that resulted in a BRAF fusion. Case 1 was likely a pilocytic astrocytoma (PA) with three deletions in 7q33q34 and an exon 15-9 KIAA1549-BRAF fusion. SNP array analysis of case 2, a possible dysembryoplastic neuroepithelial tumor (DNT), revealed a 2.6 Mb deletion, which included the 5' end of BRAF and extended to the 3' end of FAM131B. In case 3, deletions involving BRAF and FAM131B were observed in both a primary and a recurrent PA. RNA-based sequence analysis of cases 2 and 3 confirmed a fusion between FAM131B exon 2 and BRAF exon 9. The presence of fusion transcripts in these three LGGs highlights the utility of SNP array analysis to identify deletions that are suggestive of fusion proteins. BRAF fusions can result from multiple non-overlapping deletions, suggesting various complex mechanisms of formation.

Indexed as

Chromosome DeletionAdolescentBrainBrain NeoplasmsChildChromosomes, Human, Pair 7FemaleGliomaHumansMaleOncogene Proteins, FusionPolymorphism, Single NucleotideProto-Oncogene Proteins B-rafBRAF protein, humanOncogene Proteins, FusionProto-Oncogene Proteins B-rafBRAFFAM131BKIAA1549pediatric glioma

Identifiers

PMID25040262
PMCPMC4282976
OpenAlexW1528049092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.